Tobacco Addiction Clinical Trial
Official title:
Randomized Placebo Controlled Trial Assessing the Efficacy and Safety of BP1.4979 in Smoking Cessation
Clinical study which aim is to assess in heavy smokers willing to quit smoking the efficacy and the safety profile of BP1.4979 for smoking cessation on the total abstinence measured by subject diary and confirmed by exhaled CO (abstinent < 10 ppm).
BP1.4979 is a novel compound with promising efficacy on smoker which have been assessed on
phase I studies.
This is a multicenter,randomized, double blind, placebo controlled, phase IIb trial with
parallel group to assess safety and efficacy of BP1.4979 in smoker.
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT02544360 -
A Photoaging Mobile App Promoting Poster Campaign for Preventing Smoking in Secondary Schools
|
N/A | |
| Completed |
NCT00491335 -
HIV Infection and Tobacco Use Among Injection Drug Users in Baltimore, Maryland: A Pilot Study of Biomarkers
|
N/A | |
| Completed |
NCT02124200 -
High Cessation Rates in Smokers Using Personal Vaporizers
|
Phase 4 | |
| Recruiting |
NCT01038414 -
Duration of Behavioral Counseling Treatment Needed to Optimize Smoking Abstinence
|
Phase 4 | |
| Completed |
NCT02000921 -
Reduced Nicotine Content Cigarettes and Tobacco Switching Behaviors
|
N/A |